Biotech firm reports 'positive' COVID–19 vaccine trial

  • 📰 PremiumTimesng
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 78%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

The firm said its 'closely watched early-stage human trial for a coronavirus vaccine produced COVID-19 antibodies in all 45 participants used in the trial.'

A biotech firm, Moderna, has reported ‘positive’ results from its COVID-19 vaccine trial.

According to CNBC news, the declaration by the firm sent its shares to about a 20 per cent increase in value.The firm said each participant received two doses of 25 and 100 of its experimental vaccine via intramuscular injection in the upper arm closely monitored within a four week equidistance period

“Those in the 100 microgram had antibodies that “significantly exceeded levels” in recovered patients. Data on a second dose was not available for the 250 microgram group,” the company said. Meanwhile, Moderna chief medical officer, Tal Zaks, in a statement said, “These interim Phase 1 data, while early, demonstrate that vaccination with mRNA-1273 elicits an immune response of the magnitude caused by natural infection starting with a dose as low as 25 [micrograms].

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US drugmaker reports progress on COVID-19 vaccine trialUS biotech firm Moderna reported promising early results on Monday from the first clinical tests of an experimental vaccine against the novel coronavirus performed on a small number of volunteers. ... Such drugs must be certified by US_FDA in conjunction with WHO. If the drugs found its way to the Nigerian Pharmaceuticals, NafdacAgency must approve such for application and administration. This wat we call a country, not like our own wey dey new. Cat. DOg. Cup dry lie Nice one
Source: MobilePunch - 🏆 8. / 63 Read more »

COVID-19: Inmates Awaiting Trial Languish In Ondo Prisons As Courts Remain Closed | Sahara ReportersCOVID19: Inmates Awaiting Trial Languish In Ondo Prisons As Courts Remain Closed | Sahara Reporters Findings revealed that the lack of logistics, frequent adjournments, inability to pay fines, the continued absence of both lawyers and judges... READ MORE: Our judiciary system is still wack
Source: SaharaReporters - 🏆 9. / 63 Read more »

COVID-19: WHO begins clinical trial of vaccine in Nigeria as cases cross 6,000 markThe World Health Organization (WHO) has begun a clinical trial of available drugs\/vaccines for COVID-19 in Nigeria. This was confirmed by the Country Representative of the WHO, Fiona Braka, while speaking during the daily briefing of the Presidential Task Force on COVID-19 in Abuja on Monday. Lagos, Abuja, Kano, Ogun, Kaduna and Sokoto states had Is this image a nigerian doctor?😭😭 ElectoralReformsNow ElectoralReformsNow ElectoralReformsNow ElectoralReformsNow ElectoralReformsNow ElectoralReformsNow ElectoralReformsNow ElectoralReformsNow my question is China and other western countries are coming out of COVID19 without any vaccination tests. Why are they bringing this so called vaccination to Africa
Source: DailyPostNGR - 🏆 11. / 59 Read more »

Researchers launch trial to reduce severity of COVID-19 in men – Daily TrustResearchers have launched a new clinical trial that uses a hormone suppresser commonly used to treat men with prostate cancer to help improve clinical outcomes for men infected with COVID-19. The research, by University of California, Los Angeles (UCLA), published in Medical Xpress, revealed that the phase two trial will assess if temporarily suppressing male …
Source: Daily Trust - 🏆 13. / 51 Read more »